Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL

Click for more information

0.00%

0.3¢ wellfully limited

Ann: Annual Report 2017, page-46

First 46 Last

Share
Profile

Follow
smac656

3,127 Posts.

919

10/10/17

10:46

Post #: 27785325
Share

Originally posted by born2reign ↑

Hi Jace,

I haven't been able to conclude 100% what Phantom is all about. I have some working theories but I will wait for an extra piece of information or two to become available before deciding on one!

I can share with you however, with confidence, that the Olay Magnemasks product suite, despite seeing and originally having strong cases for being a Wave II or Wave III product is actually neither, so next to market is actually the Wave III product.

Personally I therefore consider/propose Magnemasks to be the "unofficial Wave 2.5" product.

Despite what has been announced previously, I have my reservations about Wave III being launched by end of 2017 (perhaps in a single country only?) and believe that a Q1 2018 launch is more practical/realistic - particularly with respect to a meaningful launch across several countries.
Time will tell and in any case, hardly makes a difference in the grand scheme of things.

The problem which caused all the confusion is to date, a product has corresponded to a Wave.. so product 1 was Wave 1 and product 2 was Wave 2 and they have caused all sorts of confusion when they referred to Magnemasks as "the third product". Logically, this should mean Wave III but for whatever reason this is not the case. So when they eventually introduce the Wave III product(s), it will be the fourth product on the market and now it's all out of sync.

It was already confusing enough as it was to decipher the ASX announcements because a Wave could consist of two physical products (Wave I consisted of an SK-II and Olay product), yet they would refer to them as the "first product" (both of them) in market updates, when in fact they are two different products/brands on shelves. Throw in Wave II and the associated SK-II creams and the various three or four products associated with Olay Magnemasks and we have 8+ unique products on shelves which can be enhanced by OBJ technology, yet with regards to market announcements, we are still just on "the third product".

The good news is we got an extra product out of the blue that wasn't on the schedule which should have been wildly celebrated by shareholders. The bad news is the confusion which arose from the botched and inconsistent communication in the corresponding announcement meant we were all scratching our heads and mostly believed it was Wave III come early and management lost a big chance to secure a marketing/communication win and begin to restore trust and repair relationsihp with shareholders.

Expand

I can share with you however, with confidence, that the Olay Magnemasks product suite, despite seeing and originally having strong cases for being a Wave II or Wave III product is actually neither, so next to market is actually the Wave III product.

Expand

The best way to think about all this is to completely ignore the talk about "Waves". When was the last time management referred to Waves III and IV? Just consider "products" because we have been told we now have 4 licenced "products", and three of these have been identified and launched :

1) eye wand (sk2, olay)
2) magnetic booster (sk2)
3) magnetic infuser (olay magnemasks)

That leaves one licensed product yet to launch, and two more (the 5th and 6th) under development but not yet licensed.

I haven't been able to conclude 100% what Phantom is all about.

Expand

phantom is magnemasks... confirmed.

Last edited by smac656: 10/10/17

OBJ Price at posting: 3.2¢ Sentiment: Buy Disclosure: Held
18 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

First 46 Last

Add WFL (ASX) to my watchlist